cilostazol has been researched along with Conus Medullaris Syndrome in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results indicate that cilostazol is neuroprotective in the chronically compressed cervical cord and is potentially useful in the treatment of cervical spondylotic myelopathy." | 7.80 | Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model. ( Kim, P; Kurokawa, R; Yamamoto, S, 2014) |
| "An 83-year-old woman taking cilostazol received caudal epidural steroid injection because of her chronic back pain." | 3.85 | Discordant lumbar epidural hematoma after caudal steroid injection: A case report (CARE-compliant). ( Chang, YJ; Choi, JJ; Jo, YY; Jung, WS; Kim, JH; Lee, KC, 2017) |
| "These results indicate that cilostazol is neuroprotective in the chronically compressed cervical cord and is potentially useful in the treatment of cervical spondylotic myelopathy." | 3.80 | Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model. ( Kim, P; Kurokawa, R; Yamamoto, S, 2014) |
| "Cilostazol was administered for 6 days orally 1 day after compression treatment group (n = 6); the nontreatment group (n = 6) did not receive any drug." | 1.35 | The effects of cilostazol on nerve conduction velocity and blood flow: acute and chronic cauda equina compression in a canine model. ( Aoki, Y; Kikuchi, S; Konno, S; Sekiguchi, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JJ | 1 |
| Chang, YJ | 1 |
| Jung, WS | 1 |
| Lee, KC | 1 |
| Kim, JH | 1 |
| Jo, YY | 1 |
| Yamamoto, S | 1 |
| Kurokawa, R | 1 |
| Kim, P | 1 |
| Sekiguchi, M | 1 |
| Aoki, Y | 1 |
| Konno, S | 1 |
| Kikuchi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471] | Phase 3 | 400 participants (Anticipated) | Interventional | 2021-12-22 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for cilostazol and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Discordant lumbar epidural hematoma after caudal steroid injection: A case report (CARE-compliant).
Topics: Aged, 80 and over; Back Pain; Chronic Pain; Cilostazol; Decompression, Surgical; Female; Fibrinolyti | 2017 |
Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model.
Topics: Animals; Cervical Vertebrae; Cilostazol; Disease Models, Animal; Male; Neurons; Phosphodiesterase 3 | 2014 |
The effects of cilostazol on nerve conduction velocity and blood flow: acute and chronic cauda equina compression in a canine model.
Topics: Action Potentials; Acute Disease; Animals; Blood Flow Velocity; Cauda Equina; Chronic Disease; Cilos | 2008 |